logy working group focuses its research on immunological issues in autologous kidneys, kidney transplants and kidney tumors in numerous own and collaborative projects. Among other things, we use digital

issues, nor is there a body that represents us or offers such opportunities. Risk management in transplantation - impact of the new Tissue Act for physicians and hospitals September 04, 2008 / 14:00 - 18:00

together with the Clinical Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation and the Institute of Transfusion Medicine organizes the block practical course "Clinical Chemistry

Tumor Center and the Clinical Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation. Contact person: Prof. Dr. med. Thomas Skripuletz Dr. med. Philipp Schwenkenbecher Dr. med. Nora

Institutions. As one of the most research-intensive medical universities in Germany, our focus is on transplantation and stem cell research, infection and immunity research as well as biomedical technology and

in the development of a transportable, artificial blood circulation system - similar to organ transplants - that keeps severed limbs viable outside the body for a longer period of time and optimally prepares

disorders. In addition, all forms of cell and immunotherapy (including allogeneic stem cell transplantation and CAR T-cell therapy) are carried out in the Clinical Cell Therapy Unit of our Clinical Department

already manufactured for your patient as well as the delivery of selected preparations for transplantation or infusion. Make sure to fill in the form completely with the data relating to the planned

provided: Priv.-Doz. Dr. med. Linda Feldbrügge, Clinical Department of General, Visceral and Transplantation Medicine , with the project "Purinergic immune regulation, mediated by CD39, in the tumor immune

Bavendiek Prof. Dr. med. J. Bauersachs Prof. Dr. med. Genot Beutel (Haematology, Stem Cell Transplantation)